Lentiviral Gene Therapy Shows Sustained Clinical Efficacy for ADA

FRIDAY, Oct. 17, 2025 (HealthDay News) -- Autologous CD34+ hematopoietic stem-cell lentiviral gene therapy shows sustained clinical efficacy for severe combined

See Full Page

Interests (0)

Settings

Lentiviral Gene Therapy Shows Sustained Clinical Efficacy for ADA

First U.S. Case of Severe Mpox Strain Without Travel History Confirmed

Respiratory Virus Season Approaches in the U.S.

Trump isn't aging well and there's a obvious reason why

'Parents aren't having children': RFK uncorks bizarre claims during IVF presser

Protein powders and shakes contain high amounts of lead, new report says

What is the average American’s No. 1 aging panic?

New Donald Trump 'Riddled With Arthritis and Knee Condition' That Could See Him Headed for Double Hip Replacement Surgery

NEO man holds record for most transplant 'dry runs' before successfully getting new lungs at Cleveland Clinic

FDA unveils drugs to receive expedited review in support of 'national priorities'

5 Everyday Foods That Can Cause Inflammation, According To Health Experts

Donald Trump Asked Queen Camilla for 'Gossip' on Meghan Markle

Two Flu Vaccine Doses Boost Benefit for Children Younger Than 3 Years

Remotely Located Technician Noninferior for Car Seat Installation

Child Neurologists Have Gaps in Awareness of Motor Impairments in ASD

Diane Keaton's Family Confirms Cause of Death

ICE leads rescue of abducted child, international fugitive in Mexico

Trump Administration Announces $20 Billion Support for Argentina

Hegseth’s plane diverted to UK due to cracked windshield on flight from Brussels to US

Los Angeles County Declares Emergency Over Immigration Raids

Prosecutors to Seek Indictment of John Bolton for Documents Case

Senators Call for Investigation into Noem's TSA Video

Orionids Meteor Shower: Where and When To Catch October Light Show's Peak

Gaza Returns to Routine After Ceasefire Agreement

John Bolton Indicted on Charges of Classified Document Misuse